Study suggests children with pneumonia only require three days of antibiotic treatment

Consumer

The Journal of the American Medical Association (JAMA) has recently released research that shows how three days of antibiotic treatment (amoxicillin) has the same impact as taking the same antibiotics for a weeklong period for children with CAP (Community Acquired Pneumonia).

The antibiotic study, which took place in November of this year, was one of the biggest trials in the world that included children. There were over 800 participants over the age of 6 months taking part, all of which had CAP (Community-Acquired Pneumonia).

“The study was one of the biggest trials in the world that included children, with over 800 participants over the age of 6 months taking part“

400 of these were given a smaller dosage of amoxicillin (35–50mg/kg) and the other 400 or so received 70–90mg/kg. The trial tested the effects of just 2 doses per day, rather than the UK government recommendations- which advise 3 daily doses.

The main result focused on if it would be necessary for these children to have more than 4 weeks of treatment. The findings concluded that the reduced treatment period had the same level of effectiveness as the extended period.

There was only one notable difference between the two groups; the length of time they experienced a cough. Children who received three days of treatment had a cough for a median of 2 days longer.

Julia Bielicki, joint first author of the study, said “The CAP-IT study provides family-friendly evidence that shorter durations of amoxicillin given twice daily are safe and effective even in young children with serious chest infections attending hospital.”

See all the latest jobs in Consumer
Return to news